Collegium Pharmaceutical Inc
COLL48.880USD
-0.450-0.91%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
1.54BMarket Cap
26.58P/E TTM
Collegium Pharmaceutical Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
631.45M
11.41%
EPS(YoY)
2.14
50.21%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its total revenue reached 631.45M, with a year-on-year change of 11.41%.
What is the Earnings Per Share (EPS) of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 2.144, with a year-on-year change of 50.21%.
What is the net income of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its net income was 69.19M, with a year-on-year change of 43.68%.
What is the net margin of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its net profit margin was 10.96%, with a year-on-year change of 28.96%.
What is the gross margin of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its gross margin was 59.76%, with a year-on-year change of 3.84%.
What is the debt-to-asset ratio of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its debt-to-asset ratio was 51.24%, with a year-on-year change of -12.19%.
What is the Return on Equity (ROE) of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its Return on Equity (ROE) was 32.62%, with a year-on-year change of 32.17%.
What is the Return on Assets (ROA) of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its Return on Assets (ROA) was 4.93%, with a year-on-year change of 18.63%.
What is the operating profit of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its operating profit was 191.31M, with a year-on-year change of 9.03%.
What are the current assets of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its current assets were 482.26M, with a year-on-year change of -10.29%.
What are the total assets of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its total assets of Collegium Pharmaceutical Inc were 1.66B, with a year-on-year change of 45.51%.
What are the total liabilities of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its total liabilities of Collegium Pharmaceutical Inc were 1.43B, with a year-on-year change of 51.36%.
What is the total equity of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its total equity of Collegium Pharmaceutical Inc was 228.84M, with a year-on-year change of 17.10%.
What is the net operating income of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its net operating income of Collegium Pharmaceutical Inc was 69.19M, with a year-on-year change of 43.68%.
What is the net investment of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its net investment of Collegium Pharmaceutical Inc was -287.76M, with a year-on-year change of -306.37%.
What is the net financing of Collegium Pharmaceutical Inc?
According to Collegium Pharmaceutical Inc's FY2024 earnings report, its net financing of Collegium Pharmaceutical Inc was -60.60M, with a year-on-year change of 56.77%.
